首页|运用新修柴胡鳖甲汤加减分期辨治肝硬化

运用新修柴胡鳖甲汤加减分期辨治肝硬化

扫码查看
以刘渡舟教授创制的柴胡鳖甲汤为基础方,化裁拟定新修柴胡鳖甲汤.提出肝硬化辨治可分三期,即肝硬化前期积之将成,肝硬化中期积之已成,肝硬化后期变证已现.临证谨守病机,辨此三期中脏腑、气血、虚实、寒热之偏重,以新修柴胡鳖甲汤为基础方加减化裁.肝硬化前期治以活血化瘀、清利湿热,同时根据病因不同灵活加减;中期治以软坚散结、化瘀清热,兼以健脾补肾;后期正气衰败,病重邪盛,治以扶正补虚、缓攻渐消,同时根据变证表现不同分别加用利水、止血、泄浊、开窍药组以治其标.
Staged Differentiation and Treatment of Liver Cirrhosis with Newly Modified Chaihu Biejia Decoction(柴胡鳖甲汤)
Based on Chaihu Biejia Decoction(柴胡鳖甲汤,CBD)created by Professor LIU Duzhou,a newly modified CBD has been formulated.The differentiation and treatment of liver cirrhosis can be divided into three stages,that is,the early stage when liver cirrhosis is about to be,the middle stage when liver cirrhosis is formulated after long accumulations,and the late stage when liver cirrhosis has been transformed.Following the pathogenesis,it is recom-mended to differentiate the abnormal exuberance of zang-fu(脏腑)organs,qi or blood,deficiency or excess,cold or heat in three stages,and newly modified CBD is taken as the basic formula for further modifications.In early stage of liver cirrhosis,the treatment is mainly to invigorate blood and dissolve stasis,clear dampness and heat,and modifica-tions should be made in accordance with the different causes flexibly.The treatment for the middle stage is to soften hardness and dissipate masses,dissolve stasis and clear heat,while fortifying the spleen and supplementing kidneys is accompanied.In the later stage when the healthy qi declines,and the disease is severe and evil prevails,the treat-ment is to reinforce healthy qi and supplement deficiency,take mild purgation and dispersion,and medicinals to pro-mote urination,stanch bleeding,direct the turbid downward,or open the orifices can be added in accordance with the syndromes so as to treat the branch.

Chaihu Biejia Decoction(柴胡鳖甲汤)liver cirrhosisstaged differentiation and treatmentLIU Duzhou

蔡雨洁、董海航、王冬凌、张引强

展开 >

山西中医药大学,山西省太原市晋祠路一段89号,030000

中国中医科学院西苑医院

柴胡鳖甲汤 肝硬化 分期辨治 刘渡舟

中国中医科学院科技创新工程项目中国中医科学院西苑医院提升中医药临床循证证据级别研究专项中国中医科学院西苑医院"青师计划"项目全国中医临床特色技术传承骨干人才培训项目山西中医药大学研究生优硕创新计划

CI2021A00805XYZX0201-23国中医药人教函[2019]36号2022YS008

2024

中医杂志
中华中医药学会 中国中医科学院

中医杂志

CSTPCD北大核心
影响因子:1.464
ISSN:1001-1668
年,卷(期):2024.65(10)
  • 18